Armata Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 25.02 million compared to USD 14.49 million a year ago. Basic loss per share from continuing operations was USD 0.69 compared to USD 0.4 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.990 USD | +2.05% |
|
-2.45% | +7.57% |

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ARMP Stock
- News Armata Pharmaceuticals, Inc.
- Armata Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024